LabCorp Commences Cash Tender Offer for All Outstanding Shares of Monogram Biosciences, Inc.

BURLINGTON, N.C. --(BUSINESS WIRE)--Jul. 1, 2009-- Laboratory Corporation of America® Holdings (NYSE: LH) today announced the commencement of its cash tender offer for all outstanding shares of the common stock of Monogram Biosciences, Inc. (NASDAQ: MGRM) for $4.55 per share.

LabCorp Enters Definitive Agreement to Acquire Monogram Biosciences, Inc.

Acquisition Price of $4.55 per Share in All Cash Transaction BURLINGTON, N.C. , SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--Jun. 23, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) and Monogram Biosciences, Inc. (NASDAQ: MGRM) today announced that they have entered

LabCorp is Scheduled to Present at the William Blair & Company 29th Annual Growth Stock Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Jun. 5, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P. King , Chairman and Chief Executive Officer, is scheduled to speak at the William Blair & Company 29 th Annual Growth Stock Conference in Chicago,

LabCorp to Strengthen Capital Structure by Redeeming Convertible Debt

BURLINGTON, N.C. --(BUSINESS WIRE)--May. 11, 2009-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH) announced today that it will exercise its option to redeem $369.1 million principal amount (at maturity) of its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon

LabCorp is Scheduled to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--May. 7, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that David P. King , Chief Executive Officer, is scheduled to speak at the Bank of America and Merrill Lynch Health Care Conference in New York, NY .

LabCorp Announces David P. King Elected Chairman of the Board

BURLINGTON, N.C., May 06, 2009 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced that the Board of Directors has elected David P. King, Chief Executive Officer, to serve as Chairman of the Board. Mr.

LabCorp(R) Scheduled to Webcast Its Annual Meeting of Stockholders

BURLINGTON, N.C. --(BUSINESS WIRE)--May. 4, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced that its Annual Meeting of Stockholders will be webcast live beginning May 6, 2009 at 9:00 a.m. Eastern Time via the Company Web site at www.labcorp.com .

Laboratory Corporation of America(R) Holdings Announces 2009 First Quarter Results

Strong Revenue Growth Drives EPS of $1.22 and Operating Cash Flow of $208.9 Million BURLINGTON, N.C. --(BUSINESS WIRE)--Apr. 23, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE: LH) today announced results for the quarter ended March 31, 2009 .

LabCorp is Scheduled to Present at the Barclays Capital Global Healthcare Conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Mar. 5, 2009-- Laboratory Corporation of America ® Holdings (LabCorp ® ) (NYSE:LH) today announced that David P. King , Chief Executive Officer, is scheduled to speak at the Barclays Capital Global Healthcare Conference in Miami Beach, FL.

LabCorp Announces Collaboration for Kannapolis-Based Biorepository

BURLINGTON, N.C., Mar 03, 2009 (BUSINESS WIRE) -- Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) today announced the signing of a collaboration agreement with Duke University related to LabCorp's state-of-the-art Biorepository in Kannapolis, North Carolina.